Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study
- PMID: 19295408
- DOI: 10.1097/PAS.0b013e318196d018
Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study
Abstract
Background: The pathologic features of ulcerative colitis (UC) in patients with primary sclerosing cholangitis (PSC) are, essentially, unknown. One previous clinical study suggested that UC-PSC patients reveal a high rate of rectal sparing and backwash ileitis. The purpose of this study was to systematically evaluate the pathologic characteristics and distribution of colonic disease in UC-PSC patients and to compare the results with a matched control group of UC patients without PSC.
Methods: Forty UC-PSC patients and 40 matched UC patients without PSC (controls) were identified from the files of 3 hospitals between the years 1989 and 2005. Clinical, endoscopic, and follow-up data (including incidence of pouchitis) were evaluated, and a detailed pathologic evaluation of biopsy and resection specimens (when available) was performed in a blinded fashion. The degree of activity and chronicity in mucosal biopsies and/or tissue from resection specimens was graded on a 5-point grading system (0 to 4), and each portion of the colon (cecum, ascending colon, transverse colon, descending colon, rectum) was assessed separately. Rectal sparing and patchiness of disease were evaluated, and scored as either absolute or relative depending on the complete absence of inflammatory disease in the former, or less inflammatory disease in the rectum compared with other parts of the colon in the latter.
Results: In this matched case-control study, UC-PSC patients presented at a significantly earlier age (24.5 y), had a higher prevalence rate of pancolitis (85%), and an overall significantly lower grade of inflammation in the colon (mean grade: 2.09+/-0.085) compared with UC controls (mean age: 33.8 y, pancolitis: 45%, inflammation grade: 2.59+/-0.92, P<0.05 for all comparisons). The incidence rate of absolute and relative rectal sparing (27.5%) and of patchy inflammatory disease proximal to the rectum (5.7%) was not significantly different between the UC-PSC cases and the UC controls (25% and 7.9%, respectively). UC-PSC patients had a higher prevalence rate of ileitis (35.7%) and pouchitis (42.8%), but the values were not significantly different from controls (26.9% and 26.6%, respectively). The incidence rate of dysplasia was similar between the 2 patient groups.
Conclusions: UC patients with PSC show a propensity for more extensive, but less active, disease but are otherwise characterized by similar pathologic findings compared with UC patients without PSC. Rectal sparing and patchy disease activity is not characteristic of UC patients with PSC.
Similar articles
-
Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy.Am J Surg Pathol. 2010 May;34(5):689-96. doi: 10.1097/PAS.0b013e3181db84cd. Am J Surg Pathol. 2010. PMID: 20410806
-
Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis.J Gastroenterol Hepatol. 2005 Mar;20(3):366-70. doi: 10.1111/j.1440-1746.2005.03727.x. J Gastroenterol Hepatol. 2005. PMID: 15740478
-
Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.Acta Gastroenterol Latinoam. 2008 Mar;38(1):26-33. Acta Gastroenterol Latinoam. 2008. PMID: 18533354
-
Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.Semin Liver Dis. 2006 Feb;26(1):31-41. doi: 10.1055/s-2006-933561. Semin Liver Dis. 2006. PMID: 16496231 Review.
-
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74. doi: 10.1097/MPG.0b013e31805563f3. J Pediatr Gastroenterol Nutr. 2007. PMID: 17460505
Cited by
-
Extraintestinal manifestations and complications in IBD.Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):585-95. doi: 10.1038/nrgastro.2013.117. Epub 2013 Jul 9. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23835489 Review.
-
Primary sclerosing cholangitis: diagnosis, prognosis, and management.Clin Gastroenterol Hepatol. 2013 Aug;11(8):898-907. doi: 10.1016/j.cgh.2013.02.016. Epub 2013 Feb 27. Clin Gastroenterol Hepatol. 2013. PMID: 23454027 Free PMC article. Review.
-
Direct health care insurer and out-of-pocket expenditures of inflammatory bowel disease: evidence from a US national survey.Dig Dis Sci. 2012 Dec;57(12):3080-91. doi: 10.1007/s10620-012-2289-y. Epub 2012 Jul 12. Dig Dis Sci. 2012. PMID: 22790905
-
Hepatopancreatobiliary manifestations of inflammatory bowel disease.Clin J Gastroenterol. 2012 Feb;5(1):1-8. doi: 10.1007/s12328-011-0282-1. Epub 2012 Jan 6. Clin J Gastroenterol. 2012. PMID: 26181867
-
Patient-reported outcome measures used in patients with primary sclerosing cholangitis: a systematic review.Health Qual Life Outcomes. 2018 Jul 5;16(1):133. doi: 10.1186/s12955-018-0951-6. Health Qual Life Outcomes. 2018. PMID: 29976215 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical